Comment Gilead did OK overall on this. (Score 1) 368
They did NOT lose money on the endeavor. They made extremely large profits for a couple years... and now it's drifted down a lot as the most financially capable potential customers have now been cured. Plus a couple competitive drugs have launched.
But... yeah, they would have done financially much better selling a $20K a year drug to keep Hep-C at bay for these same customers for the rest of their lives.
Of course, not everything is about profit maximization.... it is kind of a nice thing to save thousands of lives. (Unless you are Goldman Sachs, apparently.)